4.5.6, a skincare company specializing in products for phototypes IV, V, and VI, has successfully secured $825,000 in its latest funding round. This investment capital will support the company's mission to address a significant gap in the global beauty market by providing science-backed skincare solutions specifically formulated for melanin-rich skin. The funding announcement underscores investor confidence in 4.5.6's unique approach and market potential.
The company was founded with a clear objective: to offer bespoke skincare formulas designed to meet the distinct needs of non-Caucasian skin. These products aim to keep skin hydrated, balanced, acne-free, radiant, calm, and healthy. 4.5.6 distinguishes itself through its rigorous development process, which began with incubation at the LVMH Research Centre. Following this, the company established its own laboratory and production unit within France's Cosmetic Valley, where all research and development, formulation, production, and filling processes are conducted in-house.
This newly raised capital is earmarked to fuel 4.5.6's strategic growth initiatives. The funds will enable the company to scale its operations, potentially expand its product offerings, and enhance its reach within the underserved market of diverse skin tones. By focusing on the nuanced needs often overlooked by mainstream beauty, 4.5.6 aims to celebrate the full spectrum of skin tones that exist beyond conventional categories.
Looking ahead, 4.5.6 is positioned to continue its trajectory of innovation and market expansion. The company remains committed to its scientific approach and its dedication to providing effective, tailored skincare solutions, reinforcing its presence as a key player in inclusive beauty.
